Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
257 participants
INTERVENTIONAL
2014-05-01
2014-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Asian Clinical Evaluation of an Investigational Contact Lens for Cosmetic Effect
NCT01446835
Clinical Study of Approved and Investigational Contact Lenses
NCT02708524
Dispensing Evaluation of New Daily Disposable Toric Soft Contact Lens.
NCT01055132
Dispensing Study to Assess the Visual Performance of Optimised Prototype Contact Lenses
NCT02484586
A Clinical Comparison of 2 Multifocal Toric XR (Extended Range) Contact Lenses
NCT03006458
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
etafilcon test contact lens Variant AP
etafilcon test contact lens Variant AP
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
etafilcon test contact lens Variant JG
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
etafilcon test contact lens Variant CS
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
etafilcon test contact lens Variant VC
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
etafilcon test contact lens Variant LA
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
etafilcon test contact lens Variant JG
etafilcon test contact lens Variant AP
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
etafilcon test contact lens Variant JG
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
etafilcon test contact lens Variant CS
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
etafilcon test contact lens Variant VC
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
etafilcon test contact lens Variant LA
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
etafilcon test contact lens Variant CS
etafilcon test contact lens Variant AP
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
etafilcon test contact lens Variant JG
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
etafilcon test contact lens Variant CS
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
etafilcon test contact lens Variant VC
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
etafilcon test contact lens Variant LA
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
etafilcon test contact lens Variant VC
etafilcon test contact lens Variant AP
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
etafilcon test contact lens Variant JG
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
etafilcon test contact lens Variant CS
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
etafilcon test contact lens Variant VC
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
etafilcon test contact lens Variant LA
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
etafilcon test contact lens Variant LA
etafilcon test contact lens Variant AP
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
etafilcon test contact lens Variant JG
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
etafilcon test contact lens Variant CS
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
etafilcon test contact lens Variant VC
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
etafilcon test contact lens Variant LA
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
etafilcon test contact lens Variant AP
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
etafilcon test contact lens Variant JG
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
etafilcon test contact lens Variant CS
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
etafilcon test contact lens Variant VC
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
etafilcon test contact lens Variant LA
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Subjects must be Asian female
3. Subjects must be able to read Chinese
4. Subjects' monthly household income must be above HKD$ 10,000
5. Subjects must be habitual soft contact lens wearer or habitual limbal lens wearer or have a history of previous habitual lens wear.
6. Subjects' current/previous habitual lens must be in the disposable soft lens modality (ranging from daily to monthly)
7. Subjects must have dark colored iris (black, brown, or brown hazel)
8. Subjects must be "concept acceptors". Concept acceptors are subjects that are willing to try new circle contact lenses.
9. Subjects must be classified as either 'Classic' or 'Vogue' on a Pattern Evaluation Screening Questionnaire.
10. Subjects must have acceptable near vision (without vision correction) and be able to see the test article lenses in the mirror 30 cm or closer.
11. Subjects must have best corrected visual acuity of 20/40 (Snellen or equivalent) or better in each eye.
12. Subjects must possess a functional/usable pair of spectacles and bring them to the visit (only if applicable-to the investigators discretion)
13. Subjects must read, understand, and sign the Statement of Informed Consent
14. Subjects must appear able and willing to adhere to the instructions set forth in this clinical protocol
Exclusion Criteria
2. Habitual wearers of rigid gas permeable lenses within the last 3 months
3. Habitual soft conventional contact lens wearers (conventional lenses defined as replacement modality of greater than 1 month)
4. Any color deficiencies, by self report
5. Currently pregnant or breast-feeding a baby
6. Diabetes
7. Any ocular or systemic allergies or diseases which may interfere with contact lens wear
8. Any systemic disease, autoimmune disease, or use of medication which may interfere with contact lens wear, at the investigator's discretion
9. Any infectious diseases (e.g. hepatitis, tuberculosis) or a contagious immunosuppressive disease (e.g. HIV), by self report
10. Any grade 3 or greater Biomicroscopy findings (this includes, corneal edema, corneal staining, corneal vascularization, conjunctival injection, tarsal abnormalities, bulbar injection) on the FDA classification scale
11. Any active ocular abnormalities/conditions that may interfere with contact lens wear (this includes, but not limited to, chalazia, recurrent styes, pterygium, infection, etc.)
12. Any corneal distortion or moderate or above corneal distortion by self report
13. History of any corneal refractive surgery
14. Habitual contact lens is multifocal, monovision or worn as extended wear
18 Years
39 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johnson & Johnson Vision Care, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hung Hom, Kowloon, Hong Kong
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CR-5590
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.